Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
11/2001
11/01/2001WO1999013816A3 Liposomal camptothecin formulations
11/01/2001US20010037032 Polyunsaturated fatty acid derivatives and their use
11/01/2001US20010037020 Method for preparation of taxol
11/01/2001US20010036962 Self-emulsifying systems containing anticancer medicament
11/01/2001US20010036944 Certain benzothiazine dioxide endothelin antagonists and processes for their preparation
11/01/2001US20010036923 Complex
11/01/2001US20010036921 Osteopontin-derived chemotactic and inhibitory agents and uses therefor
11/01/2001US20010036635 Cancer screening
11/01/2001US20010036500 For enriching foods or beverages, anemia treatment
11/01/2001US20010036470 Delivery and activation through liposome incorporation of diaminocyclohexane platinum(ii) complexes
11/01/2001US20010036462 Enhancing immunology response
11/01/2001US20010036459 Cytotoxicity; therapeutic antibody
11/01/2001US20010036458 Administering mixture of antigen and genetic engineered allogenic cell
11/01/2001US20010036457 Anticancer agents
11/01/2001US20010036455 Administering neuraminidase
11/01/2001US20010036452 Interleukin-1 muteins useful as vaccine adjuvants
11/01/2001US20010036451 Embolic compositions
11/01/2001CA2407504A1 Medicine containing polysaccharide substances for activating apoptosis
11/01/2001CA2407493A1 Modulators of receptors for parathyroid hormone and parathyroid hormone-related protein
11/01/2001CA2407449A1 Novel compounds
11/01/2001CA2407445A1 Use of 5-thio-, sulfinyl- and sulfonylpyrazolo¬3,4-b|-pyridines as cyclin dependent kinase inhibitors
11/01/2001CA2407442A1 Novel medicines based on sesquiterpene mixtures
11/01/2001CA2407424A1 Retinal pigment epithelial cell lines with extended life-span and their applications
11/01/2001CA2407370A1 Heterocycles that are inhibitors of impdh enzyme
11/01/2001CA2407336A1 Method for treatment of tumors using photodynamic therapy
11/01/2001CA2407093A1 Substituted phenyl farnesyltransferase inhibitors
11/01/2001CA2407086A1 Integrin/adhesion antagonists
11/01/2001CA2407053A1 Pneumovirus ns proteins antagonize the interferon (ifn) response
11/01/2001CA2406949A1 Use of particulate vectors in immunomodulation
11/01/2001CA2406725A1 Edg8 receptor, its preparation and use
11/01/2001CA2406639A1 A thymus expressed human cytochrome p450 (p450tec)
11/01/2001CA2406264A1 Protein phosphatases
11/01/2001CA2405983A1 Human cervical cancer suppressor protein, polynucleotide encoding the protein, cell transformed with the polynucleotide and method for suppressing proliferation of cancer cell using the expression vector
11/01/2001CA2405680A1 Diagnostic assay and method of treatment involving macrophage inhibitory cytokine -1 (mic-1)
11/01/2001CA2405632A1 Intrathecal administration of rituximab for treatment of central nervous system lymphomas
11/01/2001CA2405348A1 Novel compositions derived from cranberry and grapefruit and therapeutic uses therefor
11/01/2001CA2405170A1 Method of treatment using phenyl and biaryl derivatives as prostaglandin e inhibitors and compounds useful therefore
11/01/2001CA2404998A1 Cytotoxic agents
10/2001
10/31/2001EP1149913A1 Cytokine immunoconjugates
10/31/2001EP1149910A1 Pharmaceutical composition for treating papillomavirus tumours and infection
10/31/2001EP1149903A1 ADAMTS polypeptides, nucleic acids encoding them, and uses thereof
10/31/2001EP1149586A1 Bidirectional modulation of immunity
10/31/2001EP1149584A1 Use of Photofrin as radiosensitizer
10/31/2001EP1149168A2 Comp/tsp-1, comp/tsp-2 and other tsp chimeric proteins
10/31/2001EP1149161A2 Ribozymes directed against the catalytic subunit of the human telomerase (htert)
10/31/2001EP1149159A1 Human t cell effectors expressing cd86 molecule and therapeutic use thereof
10/31/2001EP1149116A1 Process for the production of multiple cross-linked hyaluronic acid derivatives
10/31/2001EP1149114A2 Polypeptides involved in immune response
10/31/2001EP1149113A1 Use of agonists or antagonists of mip-3a in therapy
10/31/2001EP1149112A2 Ewing's tumour antigen, nucleic acid and antibodies
10/31/2001EP1149111A1 Method and composition for angiogenesis inhibition
10/31/2001EP1149106A2 4,5-azolo-oxindoles
10/31/2001EP1149105A1 4,5-pyrazinoxindoles as protein kinase inhibitors
10/31/2001EP1149091A1 4-(heterocyclylsulfonamido)-5-methoxy-6-(2-methoxyphenoxy)-2-phenyl- or pyridylpyrimidines as endothelin receptor antagonists
10/31/2001EP1149083A1 Morpholinobenzamide salts
10/31/2001EP1149080A2 Crystalline form of benzoquinoline-3-one derivative as inhibitor of 5-alpha reductase
10/31/2001EP1149072A1 Sulfonamide hydroxamates
10/31/2001EP1149069A1 Phenylglycine derivatives
10/31/2001EP1149067A1 7-aryl-6(z)heptatrienoic acid retinamides as apoptosis inducing compounds and their use as anti-cancer agents
10/31/2001EP1149063A2 Ureido-thiobutyric acid derivatives as ppar-agonists
10/31/2001EP1148902A1 Method of enhancing needleless transdermal powdered drug delivery
10/31/2001EP1148881A1 USE OF PYRIDAZINO 4,5-$i(b)]INDOLE-1-ACETAMIDE DERIVATIVES FOR PREPARING MEDICINES FOR TREATING DISEASES RELATED TO THE DYSFUNCTION OF PERIPHERAL BENZODIAZEPIN RECEPTORS
10/31/2001EP1148877A1 Methods for inhibiting bone resorption
10/31/2001EP1148876A1 Calcilytic compounds
10/31/2001EP1148875A1 Methods and compositions to enhance white blood cell count
10/31/2001EP1148779A2 Expression of secreted human alpha-fetoprotein in transgenic animals
10/31/2001EP1108428A9 Compositions for and uses thereof for treating viral disease with phenylacetate and derivatives thereof
10/31/2001EP1043988A4 C-10 carbon-substituted artemisinin-like trioxane compounds having antimalarial, antiproliferative and antitumour activities
10/31/2001EP1001799B1 Pharmaceutical composition containing peptichemio
10/31/2001EP0444181B1 C-erbb-2 external domain: gp75
10/31/2001DE10021246A1 New N-substituted benzamide derivatives are tyrosine kinase KDR and FLT inhibitors useful e.g. for treating tumors, psoriasis, rheumatoid arthritis, diabetic retinopathy or liver sclerosis
10/31/2001DE10020505A1 RSV NS Proteine antagonisieren die Interferon (IFN) Antwort RSV NS proteins antagonize the interferon (IFN) response
10/31/2001DE10019136A1 Polyamidnukleinsäure-Derivate, Mittel und Verfahren zu ihrer Herstellung Polyamide nucleic acid derivatives, means, and methods for their preparation
10/31/2001DE10019135A1 Polyamidnukleinsäure-Derivate, Mittel und Verfahren zu ihrer Herstellung Polyamide nucleic acid derivatives, means, and methods for their preparation
10/31/2001CN1320163A Method for triggering apoptosis in cells
10/31/2001CN1320127A New cytotoxic tris (oxazole)-containing macrolides
10/31/2001CN1320126A Oxazolo, thiazolo and selenazolo [4,5-C]-quinolin-4-amines and analoges thereof
10/31/2001CN1320121A Substituted 3-cyanoquinolines as protein tyrosine kinases inhibitors
10/31/2001CN1320118A Substituted 3-cyanoquinolines as protein tyrosine kinases inhibitors
10/31/2001CN1320044A Combination therapies for B-cell lymphomas comprising administration of anti-CD 20 antibody
10/31/2001CN1320042A Seletive treatment of endothelial somatostatin receptors
10/31/2001CN1320032A Alginate capsules for use in the treatment of brain tumor
10/31/2001CN1319674A Sieving method for inhibiting tumor compound and medicinal compositions containing same
10/31/2001CN1319605A Antitumour polypeptide and gene therapy vector composition
10/31/2001CN1319432A Broad-spectrum gene engineering nanometer vaccine for treating malignant tumour
10/31/2001CN1319431A Method for improving antitumor activity of amarogentin substance and its composition and evaluation method
10/31/2001CN1319424A Anticancer medicine of Annona squamose extractum and preparation method thereof
10/31/2001CN1319405A Tumor medicine
10/31/2001CN1073988C Substituted N-heteroaroylguanidin, preparation, pharmaceutical application and medicine containg same
10/31/2001CN1073860C Method for preparing radiopharmaceutical kit for bone tumour curing or diagnosis
10/31/2001CN1073846C Partial low-released peroxide dismutase inhibitor
10/31/2001CN1073843C Metastasis suppressory agents
10/30/2001US6310247 7-aryl-6(Z)-heptatrienoic acid retinamides
10/30/2001US6310226 Vitamin D analogues
10/30/2001US6310210 Water-soluble and excellent in an anti-tumor activity
10/30/2001US6310201 (3r-cis)-1-benzoyl-3-(1-methoxy-1-methylethoxy)-4-phenyl-2-aze tidinone.
10/30/2001US6310184 Immunoglobulin for the treatment and prevention of mammary and prostate gland cancers
10/30/2001US6310181 Adaptor protein FRS2 and related products and methods
10/30/2001US6310177 Compounds and methods for modulating tissue permeability
10/30/2001US6310084 Inhibitors of metalloproteases involved in tissue degradation
1 ... 1777 1778 1779 1780 1781 1782 1783 1784 1785 1786 1787 1788 1789 1790 1791 1792 1793 1794 1795 1796 1797 ... 2211